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Abstract
Cancer is one of the most common diseases worldwide and its treatment is a complex and
time-consuming process. Specifically, prostate cancer as the most common cancer among
male population has received the attentions of many researchers. Oncologists and medical
physicists usually rely on their past experience and expertise to prescribe the dose plan for
cancer treatment. The main objective of dose planning process is to deliver high dose to the
cancerous cells and simultaneously minimize the side effects of the treatment. In this arti-
cle, a novel TOPSIS case based reasoning goal-programming approach has been proposed
to optimize the dose plan for prostate cancer treatment. Firstly, a hybrid retrieval process
TOPSIS–CBR [technique for order preference by similarity to ideal solution (TOPSIS) and
case based reasoning (CBR)] is used to capture the expertise and experience of oncologists.
Thereafter, the dose plans of retrieved cases are adjusted using goal-programming mathemat-
ical model. This approach will not only help oncologists to make a better trade-off between
different conflicting decision making criteria but will also deliver a high dose to the can-
cerous cells with minimal and necessary effect on surrounding organs at risk. The efficacy
of proposed method is tested on a real data set collected from Nottingham City Hospital
using leave-one-out strategy. In most of the cases treatment plans generated by the proposed
method is coherent with the dose plan prescribed by an experienced oncologist or even better.
Developed decision support system can assist both new and experienced oncologists in the
treatment planning process.
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1 Introduction
Cancer is a disease where cells in a particular segment of the body proliferate abnormally.
Usually, cancer begins in one part of the body and spread to other parts and affects the
functionality of host and surrounding healthy organs. This process is known as metastasis.
Prostate cancer is the most common cancer in the male population (Cancer Research UK,
http://www.cancerresearchuk.org). In 2011, about 42,000 of cases of prostate cancer were
reported in UK and there were about 11,000 deaths caused by the same in 2012. In order to
prevent abnormal growth of cancerous cells, radiotherapy treatment is generally prescribed in
combination with other treatments. In radiotherapy treatment X-rays or gamma rays are used
to kill the cancerous cells. Radiation used in the treatment not only kills the cancerous cells
but also affects the surrounding normal organs. Prostate is a tiny and delicate gland located
at the base of bladder and surrounded by the urethra and rectum. Rectum is very sensitive
and usually taken care of by the oncologist during treatment process. Radiotherapy planning
is a complex and time-consuming process. Oncologists and medical physicists use different
software to determine suitable combination of different planning parameters such as number
of wedges and its configuration, number of beams, beam weight and angle between the
beams and dose in different phases of treatment, etc. In real life, oncologists in cooperation
with medical physicists perform several experiments through trial and error method to find
suitable values of above-mentioned parameters essential for the treatment. In this article, we
have focused on addressing the issues related to dose planning in radiotherapy treatment.
Appropriate dose planning has been recognized as a crucial part of cancer treatment and
in past several methods has been developed to address this problem. Romeijn et al. (2006)
proposed a linear programming approach to radiotherapy dose planning problem. The main
constraints of the developed model were hard bounds on the dose limits for normal and
cancerous cells. In this approach, various dose-planning parameters were fixed before the
optimization, which is not an easy task. Their exact values may vary from patient to patient.
In addition to that, this method could generate only one treatment plan at a time. It forces the
planner to launch a succession of experiments if multiple plans or compromises are desired.
Fiege et al. (2011) proposed a multi-objective algorithm to optimize Intensity-Modulated
Radiation Therapy (IMRT) using Genetic Algorithm. In this approach the Pareto for optimum
solutions is built using multi-objective Genetic Algorithm (GA). However, deciding which
treatment option in the Pareto frontier is the most appropriate is tedious and a complex task.
In order to deal with a new problem, the past solutions that were developed to solve the
similar problem are good indicator to remind us what solutions were successful and which of
them failed. Furthermore these past experiences could teach us about the factors essential to
success and also causing failure. Case-based reasoning is a general paradigm for reasoning
from experience. It uses a memory model for representing, indexing, and organizing past
cases and a process model for retrieving and modifying old cases and assimilating new
ones (Slade 1991; Yin et al. 2015). Case-based reasoning, a knowledge-based system is a
problem-solving approach that relies on past similar cases to find out solutions to new problem
(Kolodner 1993; Ayeldeen et al. 2015; Begum et al. 2011). CBR has proven to be especially
applicable to problem solving and decision support in the health sciences. Application of CBR
to analyze and integrate case histories and abundant anecdotal evidence on individual patients’
treatment by different doctors can lead to more reliable accounts and treatments (Bichindaritz
and Marling 2006). There have been several attempts to improve cancer decision support by
use of CBR in recent years. Teodorovic et al. (2013) has used case based reasoning approach
for dose planning in thyroid cancer. In this approach they have used Bee Colony optimization
for assigning weights to various criteria measuring similarities between new case and cases
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in the database. Ping et al. (2015) proposed a multiple measurements case-based reasoning
(MMCBR) method for liver cancer recurrence predictive models. This approach used pairing
method through time series and dynamically determined matching pairs among cases and
paired all cases in the database with new case. In this method, various similarity measures
were considered but results were not outstanding. Sharaf-El-Deen et al. (2014) combined case
based reasoning with rule based reasoning in order to improve the accuracy of case based
reasoning. Both case based reasoning and rule based reasoning used information generated
from database and did not consider any extra information.
Multi Criteria Decision Making (MCDM) is a methodological framework that aims to
provide decision makers a knowledgeable recommendation among a finite set of alterna-
tives, actions, objectives or solutions (Chai et al. 2013). Now-a-days decisions are becoming
more and more complex and involve various factors. In order to select best alternative among
several available solutions decision makers usually make a trade-off between different con-
flicting criteria. Application of MCDM frameworks is rapidly increasing due to its capability
to improve the quality of decision making by making the process more explicit, rational and
efficient than classical methods of decision-making (Oliveira et al. 2013) or decisions made
by human brain, which can consider limited amount of information at one time. MCDM
tools and techniques have been applied in many domains and successfully helped the process
of decision making, including sustainable energy management (Streimikiene et al. 2012;
Garcia-Bernabeu et al. 2016), transportation and logistics (Tzeng and Huang 2012; Tadic
et al. 2014), supply chain management (Govindan and Sivakumar 2016; Malviya and Kant
2016), budgeting (Tsai et al. 2010; Tang and Chang 2012) and managerial and strategic plan-
ning (Banihabib et al. 2016). MCDM methods are also frequently applied within health care
field. Decisions in health care area are extremely sensitive and significant, and involve sev-
eral uncertainties and complexities. They include multiple and often conflicting criteria and
objectives simultaneously and have to consider preferences and judgments of decision mak-
ers. Thus MCDM frameworks can be very helpful to support these decisions. The researches
done in health care with MCDM techniques can be categorized in four main categories:
priority setting management, public health and policy, service evaluation and diagnosis and
treatment. Taghipour et al. (2011) applied Analytic Hierarchy Process (AHP) to prioritize
medical devices in a hospital based on their significance so that devices with higher priority
score should be considered more critical and special priority is assigned to them in mainte-
nance planning. Rahimi et al. (2015) proposed a combined framework of AHP and Analytic
Network Process (ANP) to prioritize the patients to be referred to surgery. In this research
by using fuzzy soft sets and MCDM methods uncertainty involved in the waiting list priori-
tization were robustly dealt with and risk and patients medical criteria were simultaneously
considered. Santos and Garcia (2010) used AHP, Multi-Attribute Failure Mode Analysis
(MAFMA) and ELECTRE to demonstrate a decision model for incorporating indicators in
the acquisition of hospital medical equipment.
Kahraman et al. (2014) applied Fuzzy AHP to evaluate different research investment
alternatives and overcome the difficulty of measuring intangible criteria by using fuzzy sets
and not only considered cost, but also considered various criteria for this evaluation and
selection of best alternative. Liu et al. (2014) applied MCDM techniques to select an optimal
technology for the disposal of health-care waste (HCW). In the decision making process they
have considered both qualitative and quantitative factors and selected the best alternative
using novel hybrid MCDM model. The proposed model amalgamates the beauty of 2-tuple
DEMATEL techniques and fuzzy MULTIMOORA method.
Büyüközkan et al. (2011) compared fuzzy AHP with SERVQUAL (service quality)
methodology in order to evaluate quality of service in some pioneer Turkish hospitals and
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came up with the conclusion that MCDM technique can preserve the evaluation with improved
consensus. Chang (2014) proposed a framework based on the concept of fuzzy sets theory
and the VIKOR technique to provide a systematic process for evaluating the hospital service
quality where the uncertainty, subjectivity and vagueness exist. They selected five medical
centres in Taiwan as their case study and evaluated the centres through a comprehensive
empirical research by considering multiple criteria and applying linguistic terms which were
parameterised by triangular fuzzy numbers.
MCDM techniques have been widely applied within diagnosis and treatment area, and
in this paper, which is also the main area to which we applied our approach. Ferrari et al.
(2005) applied TOPSIS to evaluate Triptan treatment options in migraine. In the proposed
method tradeoff between conflicting criteria are made and seven available Triptan used in the
treatment process are ranked using TOPSIS methodology. Hartati et al. (2012) used Elimi-
nation and Choice Translating Reality (ELECTRE) method to design a multi-criteria Group
Decision Support System to determine whether a person has abnormal gene that can cause
cancer. Using TOPSIS method, La Scalia et al. (2011) developed a decision support system
for pancreatic islet transplantation. The proposed system can help doctor to calculate the
probability of transplant success in relation to four classes of identified variables (donor,
organ, isolation and recipient). Hummel et al. (2012) applied Analytic Hierarchy Process
(AHP) to evaluate the outcome of clinical antidepressant treatment. Firstly, relative impor-
tance of different decision making criteria such as remission of depression, response to drug
treatment and no relapse, etc. were determined. Thereafter, alternatives were evaluated based
on the weighted criteria. Table 1 shows other recent researches done related to diagnosis and
treatment by means of MCDM frameworks.
Oncology is a subsection of diagnosis and treatment, which also drew the attention of
few researchers in application of MCDM techniques and is the main subject of this research.
Chung et al. (2012) applied AHP to prioritize performance measures for colorectal cancer
care to facilitate the implementation of a pay-for-performance (PFP) system. They used
questionnaires responded by 48 doctors to assign the weight of criteria and their importance in
order to prioritize performance measures. Beside, Multi Attribute Decision Making literature,
Table 1 Recent researches applying MCDM in diagnosis and treatment
References MCDM method(s) Subject
Diaz-Ledezma and Parvizi (2013) AHP Evaluation of treatment methods
for cam femoroacetabular
Uzoka et al. (2011) Fuzzy AHP DSS for diagnosis of Malaria
Brasil Filho et al. (2009) ELECTRE IV Early diagnosis of Alzheimer
Vidal et al. (2010) AHP Anticancer drug production
process
Othman et al. (2015) TOPSIS Psychological Analysis of
seafarers distraction roots
BONDOR et al. (2013) VIKOR Identification of diabetic kidney
disease risk factors
Piegat and Salabun (2015) AHP-TOPSIS Assessing the severity of chronic
liver disease
Balubaid and Basheikh (2016) AHP Choosing best medicine for
patients with diabetes
Lopez and Gunasekaran (2015) Fuzzy VIKOR Selection of vaccination strategy
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reviewed previously, Multi Objective optimization also has been applied widely over various
field of health-care domain. Marques et al. (2012) proposed an integer linear programming
model to maximize the use of surgical suits. In the proposed approach rescheduling the
elective surgery from waiting list maximizes efficiency of resources installed in surgical suits.
They also developed heuristic to improve the non-optimal solutions. Güray and Güler (2013)
proposed a hierarchical goal-programming (HGP) model to address scheduling problem of
residents and the senior academic staff to outpatient clinics (OCs) in a physical medicine
and rehabilitation (PMR) department. In the past significant amount of research have been
conducted using MODM approaches to deal with optimizations regarding cancer treatment
planning (Pugachev and Xing 2002; Clark et al. 2008; Craft et al. 2012; Bertsimas et al. 2013;
Chan et al. 2014). Most of the articles related to optimization for cancer treatment focus on
beam angles and IMRT features, while there is lack of enough articles on dose planning
optimization and for prostate cancer specifically.
While the works related to CBR and MCDM with a focus on diagnosis and treatment have
been reviewed in the literature above, there have been some researches which have integrated
the principals of both approaches and demonstrated the applicability and effectiveness of the
integrated approach. However, these researches mostly focus on other domains rather than
diagnosis and treatments in healthcare.
Alptekin and Büyüközkan (2011), presented an integrated approach of AHP and CBR for
web based tourism destination planning. By applying AHP and linguistic words they assigned
the weights to cases’ attributes and then through case based reasoning and similarity between
the new case and cases in case pool the appropriate services were offered to online customers.
By applying AHP the accuracy of case matching can be enhanced. Li et al. (2011), applied the
principle of TOPSIS to CBR to predict a business failure possibility. The distance between a
case and ideal positive solutions, cases with non-failing results, and negative ideal solutions
were calculated and based on the most similar case the possibility of the business failure was
predicted. Armaghan and Renaud (2012) developed a CBR system in which in the retrieval
process, instead of k-Nearest Neighbours (k-NN) approach, they applied two outranking
methods of ELECTRE I and II. Comparisons of results showed that in their industrial dataset
their approach could improve the results obtained from CBR. Chuang (2013), applied a
hybrid model of CBR, Rough Set Theory (RST) and Grey Relational Analysis (GRA) to
enhance the performance of CBR in bankruptcy prediction. In this approach by the help of
GRA, they have calculated the weights for different attributes available and then by using
RST key attributes for CBR application have been carried out. Hu and Sun (2016), hybridized
the principle of relative Entropy and TOPSIS and developed a new similarity measure for
crisp numbers. Comparison of the developed method with Euclidean and Manhattan distance
based CBR showed improvements in the results.
The main purpose of this paper is to optimize the dose plan of radiotherapy treatment by
utilizing oncologists’ past experiences. In earlier study conducted by Petrovic et al. (2011)
a case based reasoning method was developed for radiotherapy dose planning problem. In
the proposed approach firstly four most similar cases were retrieved from the database.
Thereafter, retrieved cases were fused using Dempster-Shafer theory to generate a suitable
dose plan for new patient. Although in real life oncologists do not make decision just based on
the most similar cases treated in the past but they also take into account various other factors
such as success rate and side effects of treatment. Also, sometimes to treat the cancerous
cells they overlook the recommended dose constraint for different volume percentages of
rectum as shown in Table 2. To accomplish this purpose in another study (Malekpoor et al.
2017) we have developed a TOPSIS–Cased Based Reasoning approach in which firstly,
using case based reasoning cases similar to the new case were extracted from the database.
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Table 2 Dose limits for different
volume percentage of rectum Rectal volume % Total dose limits
66 45
50 55
25 65
10 70
Thereafter, extracted cases were evaluated using TOPSIS approach to make the tradeoff
between different conflicting criteria, and the direct dose plan associated with the selected
case from TOPSIS evaluation was prescribed for the new case. In experiments it was found
that dose plans calculated by above approach may not be an optimal one and still there is a
scope for improvement. In this study, goal programming is used to calculate the optimal dose
plans for the treatment by endeavoring to achieve nearest dose plans to oncologists’ ideal
dose plans while considering the side effects of the treatment and avoiding risks endangering
patients. This paper is organized as follow. In Sect. 2, radiotherapy dose-planning parameter
is described in detail along with limitations and potential risks. In Sect. 3, proposed solution
methodology is elucidated. Execution process of proposed method is demonstrated on a real
case in Sect. 4. Robustness and efficacy of the proposed method is discussed in Sect. 5. In
Sect. 6, conclusion and future research suggestions are provided.
2 Problem formulation
Radiotherapy planning for prostate cancer problem is a complex and time-consuming process.
The treatment is usually performed in two stages, phase I and phase II. In phase I prostate
and surrounding organs where cancer has spread is treated. While, in the second phase
only prostate will be irradiated. The main objective of treatment is to kill the cancerous
cells without affecting the functionality of surrounding organs. In Nottingham City Hospital
usually doses are prescribed in the range of 46–64 and 16–24 Gy in Phase I and II of the
treatment respectively. Prescribed total dose is usually delivered in fraction, each fraction
approximately accounts for 2 Gy. The overall process of radiotherapy treatment is explained
in Fig. 1.
Radiotherapy planning process is generally performed in several steps. Oncologist exam-
ines new patient and test the level of PSA (Prostate Specific Antigen). Prostate cancer can
increase the production of PSA, and so a PSA test looks for raised levels of PSA in the
blood that may be a sign of the condition in its early stages. Through PSA test, Digital Rec-
tal Examination (DRE) and biopsy the oncologists can detect prostate cancer and prescribe
different clinical tests such as Computed Tomography (CT) scan and Magnetic Resonance
Imaging (MRI) to determine the stage of cancer. After that, medical physicists in planning
department, by considering the results of scans, sketch the tumor volume and determine the
organs at risks so that, areas involved crucially within cancerous cells and the areas which
contain only microscopic tumor cells can be segregated. Based on the sketched volume and
characteristic of patient, different planning parameters are set by the oncologists and medical
physicist. These parameters include number of beams utilized in radiation, angle between
the beams, number of wedges, wedge angle. Also Dose Volume Histograms (DVHs) for
both phases of the treatment have an important role to help the oncologists in prescribing
a high quality treatment plan (Holder and Salter 2005). DVH is a graphical representation
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Fig. 1 Radiotherapy dose planning process
of the dose that is received by normal tissues and target volumes within a 3-D radiation
therapy plan. It allows oncologists to calculate amount of radiation that would be received
by different volume percentage of rectum. For example, if DVH value of 66% of rectum in
phase II of treatment is 0.7 and prescribed dose in phase II of treatment is 20 GY than the
dose received by 66% of rectum will be 14 GY (0.7×20 GY14 GY). Based on calculated
DVHs’ values and Clinical stage, Gleason Score and Prostate Specific Antigen (PSA) value
oncologist perform several successive experiments to determine dose in Phase I and II of
the treatment so that cancerous cells can be killed effectively without impairing the normal
organs near to the cancerous cells particularly bladder and rectum. Compared to bladder,
rectum is very sensitive organ. In a feasible dose plan dose received by different volume per-
centage of rectum must be within the constraints. The recommended dose limits of different
volume percentages of the rectum are given in Table 2. In some case these dose limits can be
overlooked to some extent so that sufficient dose can be delivered to the cancerous cells.
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3 Solutionmethodology
In the proposed approach past treated cases collected from Nottingham City Hospital are
stored in a database. Each case consists of two parts; condition of the patients, which describe
the outcome of different clinical examinations and dose plan (dose in phase I and II) prescribed
by the oncologist. The overall framework of our proposed methodology is illustrated in Fig. 2.
In the first step, cases similar to the new case are extracted from the database using case based
reasoning. Thereafter, extracted cases are evaluated using TOSPIS multi-criteria decision-
making process to make a tradeoff between success rate (maximum dose to the cancerous
cells) and side effects of the treatment. Afterward, based on parameters of the most ideal
case selected by TOPSIS method dose in phase I and II of the treatment is determined by
multi-objective integer goal programming (GP) method. The proposed approach can help
oncologist to maximize the total dose without affecting the surrounding organs. The detailed
description of each stage is given in the following sub sections.
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Table 3 Features of prostate cancer treatment
Feature Values Type of values
Stage of the cancer T1a, T1b, T1c, T2a, T2b, T3a,
T3b
Ordinal
Gleason Score [1, 10] Integer number
PSA [1, 40] Real number
DVHs [0, 1] Real number
Fig. 3 PSA fuzzy membership
3.1 Representation of the case
In order to retrieve cases similar to the new case from the database, two groups of features
i.e. clinical stage and geometry of the prostate are used to measure the similarity between a
new case and cases in database. Attributes associated with these features are listed in Table 3
and “Appendix”, describes these features in more details.
The data type, measurement unit and scale of aforementioned parameters are different.
Thus in order to develop a comprehensive similarity measure in case based reasoning we have
used fuzzy set theory to normalize these parameters in the interval of [0 1]. The parameters
and values for membership functions have been set and coordinated through Nottingham
University Hospital oncologists, which reflect their judgments and perceptions about Gleason
Score and PSA values.
The membership functions of each feature l (Gleason Score (l 1), PSA (l 2)) of case
C p are represented by a triplet (νpl1, νpl2, vpl3), where νplm , m1, 2, 3 are membership
degrees of feature l to fuzzy sets low (m=1), medium (m=2) and high (m=3).
The membership functions of PSA and Gleason Score are shown in Figs. 3 and 4 respec-
tively.
3.2 Retrieval process of similar cases
During the discussion with oncologist it was found that clinical stage is an important decision
making criteria. Usually, patient with similar clinical stage share same kind of treatment.
Clinical stage can be arranged in the following sequence {T1a, T1b, T1c, T2a, T2b, T3a,
T3b}. Corresponding to each new patient firstly cases having same clinical stage or adjacent
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Fig. 4 Gleason score fuzzy membership
to the new case are extracted from the database. Thereafter, from the filtered list cases similar
to the new case are retrieved.
Distance between new case C p and case in the database Cq is calculated using Eq. (1).
It takes into consideration fuzzy membership values of Gleason Score (l=1) and PSA value
(l=2).
d1
(
C p, Cq
) 
( 2∑
l1
3∑
m1
(
νplm − νqlm
)2
) 12
(1)
Taking into account numerical values of different DVH volume percentage of rectum
(b  1) 66%, (b  2) 50%, (b  3) 25% and (b  4) 10% distance between new case C p
and case in the database Cq is calculated using Eq. (2). In this equation (h= 1, 2) represents
the phase of treatment. u phb and uqhb are the values of dose received for each percentage of
the rectum in phase 1 and 2 of the treatment and is calculated based on DVH values.
d2
(
C p, Cq
) 
( 2∑
h1
4∑
b1
(
u phb − uqhb
)2
) 12
(2)
Overall similarity measure between cases C p and Cq is measured using Eq. (3).
S
(
C p, Cq
)  1
1 + d1
(
C p, Cq
)
+ d2
(
C p, Cq
) (3)
3.3 Solutionmethodology for improving CBR
In simple case based reasoning usually decision is based on the most similar extracted case.
However, sometime in radiotherapy dose-planning process the most similar case may not be
the most appropriate case to make decision. In addition to similarity there are other criteria,
which can have more impact on the preference of a case over other cases. In the experiment, it
was found that the case which has a high similarity measure is not always the most appropriate
case to make decision, because sometimes they have low success rate or dose received by
different volume percentages of rectum surpass the restrictions as shown in Table 2. In order
to solve the aforementioned problem firstly, cases similar to new case are retrieved from the
database thereafter cases are evaluated using TOPSIS technique to make a trade-off between
similarity measure, success rate and side effect of treatment.
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3.3.1 TOPSIS methodology
TOPSIS (Technique for Order Preference by Similarity to an Ideal Solution) is a MCDM
method developed by Hwang and Yoon (1981). The main purpose of this technique is to
rank different alternatives based on their distances from ideal positive and negative solution.
TOPSIS can be performed using following steps:
At the beginning of the process a decision Matrix D is constructed. The row of each matrix
represents alternatives, while column represents different criteria.
DM  [yi j
] 
⎡
⎢
⎣
y11 · · · y1r
.
.
.
.
.
.
.
.
.
yn1 · · · ynr
⎤
⎥
⎦ (4)
where yi j (i  1, . . . , n; j  1, . . . , r ) are the elements of the decision matrix D.
Thereafter, following steps are performed to select best alternative:
Step 1 Decision Matrix is normalized using Eq. (5):
Ri j  yi j√∑ j
j1 yi j
(5)
Ri j is the normalized value of element yi j in decision matrix.
Step 2 Weighted normalized decision matrix is calculated using Eq. (6).
vi j  wi Ri j (6)
Step 3 Positive and negative ideal solutions are specified using Eqs. (7) and (8) respectively:
P I S  {v∗1 , . . . , v∗r
} 
⎧
⎪⎪⎨
⎪⎪⎩
max
j
vi j
∣∣∣∣i ∈ bene f i t
min
j
vi j
∣∣∣∣i ∈ cost
(7)
N I S  {v−1 , . . . , v−r
} 
⎧
⎪⎪⎨
⎪⎪⎩
min
j
vi j
∣∣∣∣i ∈ bene f i t
max
j
vi j
∣∣∣∣i ∈ cost
(8)
Step 4 Distance of each alternative from Positive Ideal Solutions (PIS) and Negative Ideal
Solutions (NIS) are calculated using Eqs. (9) and (10) respectively.
D+j 
√√√√
n∑
i1
(
vi j − v∗i
)2 (9)
D−j 
√√√√
n∑
i1
(
vi j − v−i
)2 (10)
Step 5 Finally, relative closeness coefficient is calculated using Eq. (11) and alternative
with higher coefficient is ranked better.
C∗j 
D−j
D−j + D+j
(11)
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In our proposed method extracted cases are evaluated based on similarity measures, success
rate (total prescribed dose, dose in phase I and II of treatment) and side effects of treatment
(deviation from recommended dose limit of different volume percentage of rectum as
given in Table 2). Similarity measure, total dose and dose in phase I of the treatment is
considered as our positive weighted criteria and are given more importance than others.
Dose in phase II of the treatment is considered as negative weighted criteria which means
that cases having higher value of dose in phase II of treatment is given less importance in
decision making process. The weights for all the criteria have been considered the same
for this research. The full description of criteria can be found in Malekpoor et al. (2017).
3.4 Optimizing the final dose plan
During the study it was found that sometimes dose plan suggested by TOPSIS–CBR is not
an optimal dose plan and there is a scope for improvement. On the other hand, sometimes-
calculated dose plan is not suitable for a new case. It violates recommended dose limits
associated with different volume percentages of the rectum. To solve the above problem
optimization of dose planning is performed using integer goal programming mathematical
model, where the deviation from DVH recommended values is calculated by the help of best
similar case suggested by CBR–TOPSIS. Thereafter, deviations corresponding to different
volume percentages of rectum are calculated using Eq. (12):
S pv  dq1 DV H1pv + dq2 DV H2pv − Recomended standard (12)
where S pv represents deviation of a new case p corresponding to different volume percentage
of rectum v (v 66, 50, 25, 10%). dq1 and dq2 represent dose of extracted case in phase I and
II of treatment respectively. DV H1 and DV H2 are the values for Dose Volume Histograms
of the new case which are available for each new case and have been also used in finding
similarity measure of the case based reasoning. An example of these values for each case is
available in Table 4, columns 3–10.
This value determines the suitability of solution prescribed by CBR–TOPSIS method by
calculating amount of dose received by different volume percentage of the rectum.
To treat cancerous cells, in real life sometime oncologists overlook recommended dose
limit. The amount of deviation from recommended limit is usually based on oncologists’ past
experiences. To employ the knowledge and expertise of oncologist, in this article, deviations
are calculated based on extracted past treated patients’ information stored in the database.
3.4.1 Goal programmingmethodology
Goal programming is basically a multi-objective linear optimization tool, which helps solu-
tion to move towards ideal goal. Goal programming consists of following attributes: an
objective function, a set of limitations related to goals and systematic constraints. The aim
of objective function is to minimize deviations from the given goals as far as possible. The
deviation in the objective function is usually weighted to define the priority of some of them
to the others. Mathematical formulation of the goal programming is as follows:
minZ 
n∑
j1
(
wkd+k + wkd
−
k
) (13)
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s.t.
f (x1, . . . , xi , . . . , xM )k − d+k + d−k  gk k  1, 2, . . . , n; and i  1, 2, . . . , M ; (14)
AX ≤ or ≥ B (15)
where X is a set of variables, that is, X  {x1, x2, . . . , xM }, A is a matrix consisting of
coefficient for variables in our systematic constraints, B is a matrix for right side values of
systematic constraints and gk represents the goal corresponding to constraint k.
d+k and d
−
k are the auxiliary variables that demonstrate the upper and lower deviations
from the goal gk . In objective function, we try to minimize deviations to satisfy the goals.
wk is the importance of the kth goal compared to other goals. As can be seen, the deviations
include positive and negative deviations from the considered goal. Minimization procedure
is done only on the undesired deviation and thus only the undesired deviation appears in the
final objective function of the problem.
If the goal is to achieve more than a certain value, then GP tries to minimize the negative
deviation from the goal and positive deviation is going to be maximized automatically as
much as the hard constraints allow it to and the opposite happens if the goal is to achieve less
than a certain value.
If the goal is to achieve precisely equal to a value, then both of the negative and positive
deviations are considered as undesired deviations and objective function tries to minimize
both of the deviations.
During the discussion with oncologists it was found that the main objective of dose
planning process is to maximize overall prescribed total dose while respecting the dose
corresponding to different volume percentage of rectum. If the two-dose plans have same
value of total dose and dose received by different volume percentage of rectum is within the
constraint the dose plan having higher amount of dose in first phase of treatment is considered
as a better dose plan compared to others. In this article goals are set based on abovementioned
criteria. Goal objectives are as follows:
Objective 1: Goal objective of the total dose plan is to assign maximum amount of recom-
mended dose in our case pool.
Objective 2: Goal objective of the dose in Phase I of the treatment is to deliver maximum
or amount of dose prescribed in phase I in our case pool or higher.
Objective 3: Goal objective of the dose plan in Phase II of the treatment is to assign
maximum amount of dose prescribed in phase II in our case pool or higher.
Figure 5 shows the Process of modeling the GP problem.
The first step is to running CBR–TOPSIS and obtain the best case corresponding to a
new case. Thereafter, in the second step by using the dose prescribed by the best case from
Selection of the best-
ranked cases from case 
base using TOPSIS 
evaluation
Use the dose plan 
prescribed for the selected 
case
Calculate allowed 
deviation for 50% of 
the rectum
Calculate allowed 
deviation for 66% of 
the rectum
Calculate allowed 
deviation for 25% of 
the rectum
Calculate allowed 
deviation for 10% of 
the rectum
Considering the ‘Goals’ 
for objective function and 
‘allowed deviations’ as 
our constraints add 
technical constraints
Fig. 5 The process of modeling GP problem by using CBR and TOPSIS results
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CBR–TOPSIS and DVH values related to the new case based on Eq. 12, allowed deviations
from different volume percentages of the rectum (S pv ) is calculated. Through Objectives 1–3
the goals for GP are set and with the help of the calculated allowed deviations the hard
constraints of the GP are defined.
The mathematical formulation for integer goal programming related to prostate cancer
dose planning process is as follows:
min Z 
3∑
j1
(
wkd+k + wkd
−
k
) (16)
x1 + x2 − d+1 + d−1  g1 (17)
x1 − d+2 + d−2  g2 (18)
x2 − d+3 + d−3  g3 (19)
DV H1p66%x1 + DV H
2p
66%x2 + S
p
66% ≤ 45; (20)
DV H1p50%x1 + DV H
2p
50%x2 + S
p
50% ≤ 55; (21)
DV H1p25%x1 + DV H
2p
25%x2 + S
p
25% ≤ 65; (22)
DV H1p10%x1 + DV H
2p
10%x2 + S
p
10% ≤ 70; (23)
x1, x2 ≥ 0 and integer; (24)
d+,−1 , d
+,−
2 , d
+,−
3 ≥ 0; (25)
where k  1, 2, 3, the goals; x1 and x2, dose plan in phase I and II of the treatment; w j
weight of kth goal; d+k , positive deviation from the kth goal; d
−
k , negative deviation from the
kth goal; g1, g2 and g3, goal objectives; DV H1p66,50,25,10%, DVH values of the new case p,
in the first phase of treatment corresponding to 66, 50, 25 and 10% of the rectum volume;
DV H2p66,50,25,10%, DVH values of the new case p, in the second phase of treatment corre-
sponding to 66, 50, 25 and 10% of the rectum volume; S p66,50,25,10%, the amount of deviation
oncologists committed corresponding to different volume percentage of rectum for the new
case p.
While x1 and x2 are the values of dose plan in phase I and II of the treatment respectively,
x1 + x2 equals to total dose plan of the treatment. There are three goals (objectives) in
our problem which are explained in this section above (Sect. 3.4.1) and are k  1, 2, 3
respectively in the above model. DVH values for each phase of the treatment and each
percentage of the rectum volume is available in our data set (total of 8 values for each case)
and S p for each volume of the rectum is being calculated by expression 12.
Equation (16) is the objective function for minimizing the deviations from our goals.
Equations (20)–(25) are our goal related constraints, which determine deviations from total
dose plan, dose plan in Phase I and II of the treatment respectively. Equations (17)–(19) are our
systematic goals which restrict the optimization process to find solutions without violating
the recommended doses based on oncologists suggestions and pre-prescribed standards.
Equation (24) helps to achieve positive integer values for our dose plan.
In above GP model, we try to optimize (finding a solution as much as possible near to
ideal goals) the total amount of dose plan, dose in phase I and Phase II of the treatment so that
we can prescribe an optimal treatment. To achieve above objective firstly we have calculated
possible deviations from recommended standards (as shown in Table 2) using CBR–TOPSIS
method and consider it as constraints to our goals. Thereafter, optimal combination of total
dose, dose in Phase I and II of treatment is generated while satisfy the considered constraints.
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3.5 Maximization of dose plan within safe risk zone
If dose received by different volume percentages of rectum is within the constraint the dose
plan is acceptable. The higher the total dose, more likely the probability is to kill the cancerous
cells. Hence, where there are positive S pv it means more dose can be prescribe without deviat-
ing prescribed dose limit. Higher dose can kill the cancer cells without causing any significant
damage to rectum and in exchange can increase the chance of eradicating cancerous cells.
In the final step modification is performed to minimize the deviation from recommended
standards as described in Eq. (26).
S pv 
{
S pv i f ≥ 0
0 i f ≤ 0 (26)
In real life sometimes to treat cancerous cells oncologists overlook the recommended dose
limit associated with different volume percentage of rectum. Similarly, in our proposed model
the system will retrieve the past similar cases and based on extracted cases it will decide the
dose limit associated with different volume percentage of rectum. The proposed model will
overlook the recommended dose limit if oncologist has performed similar decision in the
past. Once the dose limit is set, goal programing method will search for the optimal dose
plan.
3.6 Modification rule for integer programming
Usually, dose is delivered in 2 Gy packs. Hence, dose in phase I and II of the treatment must
be an even number. In order to solve the problem of odd numbers the following conditions
are incorporated in programming:
1. If calculated dose in phase I or phase II of treatment is an odd number then:
a. Increase the dose by 1 Gy. If dose received by different volume percentages of rectum
violate the constraint then decrease the dose by 1 Gy.
2. If dose plan in both Phases of the treatment is odd number then:
a. Increase the dose plan in the both phases of the treatment by 1 Gy and check the limitation
suggested by oncologists. If violated go to step b.
b. Increase the dose plan in phase I by 1 Gy and decrease dose plan in phase II by 1 Gy.
Check the limitation suggested by oncologists. If violated go to step c.
c. Decrease the dose plan in phase I by 1 Gy and increase dose plan in phase II by 1 Gy.
Check the limitation suggested by oncologists. If violated go to step d.
d. Decrease the dose in phase I and II of treatment by 1 Gy
4 Numerical example
In this section, a numerical example is considered to illustrate the execution process of
proposed method. In this example a case from our database is extracted and assumed as a
new case. Firstly, cases having same clinical stage or adjacent to the new case are extracted
from the database. Thereafter, from extracted cases five most similar cases are retrieved
and evaluated using TOPSIS method. The features value of five selected cases are depicted
in Table 4. Corresponding to each five cases the numerical value of different evaluation
criteria used in TOPSIS is shown in Table 5. Subsequently, distance from PIS and NIS are
calculated to find closeness coefficients as shown in Table 6. In the given example, case 4
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Table 5 Numerical value of evaluation criteria used in TOPSIS
Alternatives Criteria
Dose plan
in Phase I
Dose plan
in Phase II
Deviation
S66%
Deviation
S50%
Deviation
S25%
Deviation
S10%
Similarity
measure
(%)
Case 1 54 18 9.36 13.78 3.26 0.56 92.08
Case 2 46 24 10 15.6 2.04 3.78 83.51
Case 3 46 24 10.26 11.26 0.5 0.94 83.06
Case 4 46 24 6.98 11.88 0.78 1.16 79.4
Case 5 46 24 8.6 16.98 2.26 1.4 79.15
Table 6 Distance from positive
and negative ideal solution NIS PIS CC Rank
Case 1 0.012004 0.0078994 0.60311 3
Case 2 0.0015172 0.014866 0.092607 5
Case 3 0.016934 0.0011271 0.9376 2
Case 4 0.014567 0.0009643 0.93791 1
Case 5 0.0072704 0.0051079 0.58735 4
Table 7 Deviations from recommended dose limit
Rectum volume 66% of rectum 50% of rectum 25% of rectum 10% of rectum
Allowed deviations −10.7200 −15.6400 −5.2000 −0.9400
Table 8 Average similarity measure between first t similar case and a new case
Number of similar
cases
t3 t4 t5 t6 t7
Average similarity
measures
85.2% 83.6% 81.1% 70.5% 63.2%
has higher closeness coefficient compared to other cases and thus is selected as our guide (as
an oncologist opinion) to calculate deviations from recommended standard. Thereafter, with
the help of Eq. (12) the deviations from recommended dose limit is calculated as illustrated
in Table 7.
We have selected initial number of similar cases (i.e. five in this study) based on average
similarity measure between a new case and cases in the case base. One-by-one all the cases
from the data base have been retrieved and treated as a new case and average similarity
measure between t  3, 4, 5, 6 and 7 most similar cases to them was calculated and results
are shown in Table 8. During experiments it was found that as we move forward from 5 to 6
similar cases the average similarity measure of t cases with the new case significantly reduces
from 81.1 to 70.5% and moreover some outliers with less than 50% similarity to a new case
were found. Based on above fact in this article we have retrieved 5 most similar cases as our
initial number for the dose planning process.
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To optimize the dose plan goal programming is formulated. Based on the expert opinion
of oncologists the weight associated with total dose, dose in phase I and II of treatment
are set as 0.70, 0.25 and 0.05 respectively. Here, higher weight is assigned to the total
dose of treatment to maximize the overall recommended dose. When the maximum total
dose is achieved the next goal is to maximize the dose in phase I of the treatment. In Not-
tingham City Hospital maximum total dose, highest dose in phase I and II of treatment
are prescribed as 74, 64 and 14 Gy respectively. Hence, in our model constraint related to
maximum total dose, dose in phase I and II of treatment is set as 74, 64 and 14 Gy respec-
tively.
The overall goal programming for the selected case is as follows:
min Z  0.7d+1 + 0.7d−1 + 0.25d−2 + 0.05d−3
x1 + x2 − d+1 + d−1  74
x1 − d+2 + d−2  64
x2 − d+3 + d−3  14
DV H166%x1 + DV H
2
66%x2 + 10.72 ≤ 45;
DV H150%x1 + DV H
2
50%x2 + 15.64 ≤ 55;
DV H125%x1 + DV H
2
25%x2 + 5.2 ≤ 65;
DV H110%x1 + DV H
2
10%x2 + 0.94 ≤ 70;
x1, x2 ≥ 0 and integer;
d+,−1 , d
+,−
2 , d
+,−
3 ≥ 0;
Based on three objectives considered for the problem (Sect. 3.4.1) and explanation in
Sect. 3.4.1 on positive and negative goal deviations, here in this problem we try to minimize
both d+1 and d
−
1 to direct the final results as much as possible towards the maximum amount
of total dose plan available. Also, in order to achieve the equal or higher amount of available
dose plans in phase I and II of the treatment we only try to minimize the undesirable negative
deviations of d−2 and d
−
3 .
Due to positive values of DVH violations (S p ≥ 0), there is a scope for improve-
ment. To determine the dose limit of different volume percentage of rectum we eliminate
all the Sk based on what we described in Sect. 3.5. After solving the linear integer
goal programming the value of dose in Phase I and II of treatment is 56 and 14 GY
respectively, which is within the safe recommended limit without exceeding recommended
standards.
5 Experimental results
In order to examine effectiveness of the proposed methodology we applied an approach called
leave one out strategy. Anonymous patient records of past treated patients are collected from
Nottingham City Hospital and stored in the database. In our database we have total 69
cases. In leave-one-out approach, cases stored in our case base are extracted one-by-one and
considered as a new case. The dose plan related to each of the taken out cases is calculated
through the proposed methodology and the result is compared with the dose plan prescribed by
oncologist. If there is any discrepancy among the dose plan computed by our methodology and
the prescribed by the oncologists’ then firstly dose received by different volume percentage
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of rectum is calculated. If dose received by the different volume percentages of rectum are
less than or equal to the recommended limit then the quality of dose plan is judged based
on following conditions. The dose plan having higher amount of total dose is considered as
a better dose plan compared to other because while radiation received by rectum is in safe
zone (lower than recommended standards) the probability of killing cancerous cells without
damaging surrounding organs, specially rectum, is higher and chances for patient to live
cancer free will be higher thus a dose plan having maximum amount of total dose will help to
kill cancerous cells more efficiently and simultaneously oncologists can be confident about
side effects of the treatment (Mishra et al. 2011). However, if two plans have same amount of
total dose then the quality of the plan is judged based on amount of dose prescribed in Phase I
of treatment. In Phase I of the treatment both cancer and its surrounding organs where cancer
has spread is treated. The dose plan having higher amount of dose in phase I of treatment
is considered as better dose plan compared to other dose plans which have less amount of
dose in phase I of treatment. If the dose plan generated by the proposed system is equal or
better (based on abovementioned criteria) compared with oncologist prescription then it is
considered as a successful case.
The success rate of proposed method is 87.6%. In 57 cases (out of 65 cases) dose plan
suggested by proposed method is same as prescribed by oncologist or even better. More
precisely, in 29 cases it generates a better dose plan. Further in order to demonstrate the suit-
ability of TOPSIS and goal programing method it is compared with CBR and CBR–TOPSIS
as shown in Table 9 and Fig. 6. It can be noticed that the performance of CBR–TOPSIS Goal
programing is better than other approaches.
Table 9 Comparison of the proposed methodology with approaches
Different approaches Simple CBR CBR + TOPSIS CBR + TOPSIS +
Modification rule
CBR + TOPSIS +
GP
Success rate (%) 73.43 83.6 86.88 87.6
Number of cases with
better dose plan
15 18 20 29
0
5
10
15
20
25
30
35
65
70
75
80
85
90
CBR CBR+TOPSIS CBR+TOPSIS/MR CBR+TOPSIS+GP
Experimental Results Comparison
Success Rate (le axis) Beer Dose plans (right axis)
Fig. 6 Graphical representation of success rate
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Table 10 success rate of the approach by considering different number of similar cases
Success rate Number of cases
t3 t4 t5 t6 t7
Success rate (%) with CBR +
TOPSIS + GP approach
75.3 80 87.6 87.6 87.6
Number of cases with better dose
plan
17 21 29 29 29
Also in order to further consider the number of retrieved most similar cases to be considered
in TOPSIS evaluation, the whole experiment has been done for t  3, 4, 5, 6, and 7 most
similar case to a new case and results are shown in Table 10. Increasing the number of most
similar cases from 4 to 5, success rate of the process increased by 7.6%. Increasing the
number of cases from 5 to 6 to 7 cases did not have any effect on the outcome of the process
simply because the extra similar cases due to their low similarity to the new case, were not
evaluated effective by TOPSIS to be considered as the reference case for GP optimization.
6 Conclusion
Health is an essential component of sustainable human development. Better treatment in min-
imum cost by adopting new technology will empower sustainable development of society.
Cancer is one of the most common diseases worldwide. In this paper a novel approach
to radiotherapy dose planning is proposed and results have been precisely investigated.
A three stages approach is recommended. In the first step cases similar to the new case
are extracted from the database using case based reasoning approach. In experiment it
was found that sometimes a case is similar to the new case but has low success rate
compared to other non-similar cases. In real life similarity measure is not only a decision-
making parameters. In decision-making process oncologist make a trade-off between various
parameters. Also, to treat cancerous cells sometime oncologist overlooks recommended
dose limit. The amount of deviation from recommended limit is usually based on oncol-
ogists’ past experience’. To accomplish the same, extracted five most similar cases are
evaluated using TOPSIS, a multi criteria decision-making technique and dose limit of dif-
ferent volume percentage of rectum is calculated. Finally, goal programming is used to
decide optimal dose in phase I and II of treatment. The robustness of proposed method
is tested on real data sets collected from Nottingham City Hospital using leave-one-out
strategy. In experiments it was found that proposed system not only help oncologists
to make a trade-off between different decision-making criteria, but also help to decide
optimal dose plan for the treatment. In future, some extra parameters such as fitness of
patients, side effects during and after the treatment can be taken into account in CBR sys-
tem.
OpenAccess This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and repro-
duction in any medium, provided you give appropriate credit to the original author(s) and the source, provide
a link to the Creative Commons license, and indicate if changes were made.
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Appendix: Medical features used in Table 2
Clinical stage A labelling system indicating the local extent of a prostate tumor and its spread to
surrounding organs. It includes T1a, T1b, T1c, T2a, T2b, T3a, T3b categories
DVH A graphical representation of the dose that is received by normal tissues and target
volumes within a 3-D radiation therapy plan. They provide information on the volume
of a structure receiving a given dose over a range of doses. In Prostate cancer
radiotherapy, rectum’s volumes of interest are 66, 50, 25 and 10%
Gleason Score A classification of prostate cancer grade on the basis of histology with predictive value for
progression. The values are in range of 1–10. Cancers with a higher Gleason score are
more aggressive and have a worse prognosis
PSA Prostate Specific Antigen, The PSA test measures the level of PSA in a man’s blood.
Elevated amounts of PSA could be result of inflammation of the prostate, infection or
prostate cancer. The values are within the range of 1–40
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